The significant variation in EFTUD2 expression, its association with PFS, and its intricate connections with the mRNA splicing machinery underscore the need for a more nuanced understanding of its role in ccRCC. This evidence concerns the gene EFTUD2 and nonpapillary renal cell carcinoma.